Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak

This study aims to explore disease patterns of coronavirus disease (COVID-19) in patients with rheumatic musculoskeletal disorders (RMD) treated with immunosuppressive drugs in comparison with the general population. The observational study considered a cohort of RMD patients treated with biologic d...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonaglia, Arianna, Comoretto, Rosanna, Pasut, Enrico, Treppo, Elena, Del Frate, Giulia, Colatutto, Donatella, Zabotti, Alen, De Vita, Salvatore, Quartuccio, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316145/
https://www.ncbi.nlm.nih.gov/pubmed/35891442
http://dx.doi.org/10.3390/v14071462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316145/
https://www.ncbi.nlm.nih.gov/pubmed/35891442
http://dx.doi.org/10.3390/v14071462

Ejemplares similares